Effects of SA4503, a novel sigma1 receptor agonist, on monoamine metabolism in the brain of mice exposed to tail-suspension

被引：0
|
作者：
Ukai, M
Maeda, H
Hiramatsu, M
Kameyama, T
Matsuno, K
机构：
[1] Meijo Univ, Fac Pharmaceut Sci, Dept Chem Pharmacol, Nagoya, Aichi 4688503, Japan
[2] Santen Pharmaceut Co Ltd, Cent Res Labs, Osaka 5338651, Japan
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 1998年 / 358卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P3571
引用
收藏
页码：R45 / R45
页数：1
相关论文
共 31 条
  • [21] Preclinical evaluation of [11C]SA4503: radiation dosimetry,in vivo selectivity and PET imaging of sigma1 receptors in the cat brain
    Kazunori Kawamura
    Kiichi Ishiwata
    Yuhei Shimada
    Yuichi Kimura
    Tadayuki Kobayashi
    Kiyoshi Matsuno
    Yoshio Homma
    Michio Senda
    Annals of Nuclear Medicine, 2000, 14 : 285 - 292
  • [22] SA4503, a sigma-1 receptor agonist, suppresses motor neuron damage in in vitro and in vivo amyotrophic lateral sclerosis models
    Ono, Yoko
    Tanaka, Hirotaka
    Takata, Masafumi
    Nagahara, Yuki
    Noda, Yasuhiro
    Tsuruma, Kazuhiro
    Shimazawa, Masamitsu
    Hozumi, Isao
    Hara, Hideaki
    NEUROSCIENCE LETTERS, 2014, 559 : 174 - 178
  • [23] SA4503, a sigma-1 receptor agonist, suppresses motor neuron damage in in vitro and in vivo amyotrophic lateral sclerosis models
    Ono, Yoko
    Tanaka, Hirotaka
    Takata, Masafumi
    Nagahara, Yuki
    Noda, Yasuhiro
    Tsuruma, Kazuhiro
    Shimazawa, Masamitsu
    Hozumi, Isao
    Hara, Hideaki
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2014, 124 : 152P - 152P
  • [24] Phase II Trial of the Sigma-1 Receptor Agonist Cutamesine (SA4503) for Recovery Enhancement After Acute Ischemic Stroke
    Urfer, Roman
    Moebius, Hans J.
    Skoloudik, David
    Santamarina, Estevo
    Sato, Wakao
    Mita, Shiro
    Muir, Keith W.
    STROKE, 2014, 45 (11) : 3304 - 3310
  • [25] Effect of a sigma-1 receptor agonist, cutamesine dihydrochloride (SA4503), on photoreceptor cell death against light-induced damage
    Shimazawa, Masamitsu
    Sugitani, Sou
    Inoue, Yuki
    Tsuruma, Kazuhiro
    Hara, Hideaki
    EXPERIMENTAL EYE RESEARCH, 2015, 132 : 64 - 72
  • [26] The Reversal Effect of Sigma-1 Receptor (S1R) Agonist, SA4503, on Atrial Fibrillation After Depression and Its Underlying Mechanism
    Liu, Xin
    Qu, Chuan
    Shi, Shaobo
    Ye, Tianxin
    Wang, Linglin
    Liu, Steven
    Zhang, Cui
    Liang, Jinjun
    Hu, Dan
    Yang, Bo
    FRONTIERS IN PHYSIOLOGY, 2019, 10
  • [27] Studies on drug dependence (Rept. 490): Effect of the sigma-1 receptor agonist SA4503 on the oxaliplatin- and paclitaxel-induced allodynia in rats
    Masumoto, Aki
    Mori, Tomohisa
    Harumiya, Masato
    Oya, Jumpei
    Fukase, Mika
    Shibasaki, Masahiro
    Suzuki, Tsutomu
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2014, 124 : 185P - 185P
  • [28] The Reversal Effect of Sigma-1 Receptor (S1R) Agonist, SA4503, on Atrial Fibrillation After Depression and Its Underlying Mechanism (vol 10, 1346, 2019)
    Liu, Xin
    Qu, Chuan
    Shi, Shaobo
    Ye, Tianxin
    Wang, Linglin
    Liu, Steven
    Zhang, Cui
    Liang, Jinjun
    Hu, Dan
    Yang, Bo
    FRONTIERS IN PHYSIOLOGY, 2022, 13
  • [29] SA4503, a sigma-1 receptor agonist, prevents cultured cortical neurons from oxidative stress-induced cell death via suppression of MAPK pathway activation and glutamate receptor expression
    Tuerxun, Tuerhong
    Numakawa, Tadahiro
    Adachi, Naoki
    Kumamaru, Emi
    Kitazawa, Hiromi
    Kudo, Motoshige
    Kunugi, Hiroshi
    NEUROSCIENCE LETTERS, 2010, 469 (03) : 303 - 308
  • [30] Ether modifications to 1-[2-(3,4-dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)piperazine (SA4503): Effects on binding affinity and selectivity for sigma receptors and monoamine transporters
    Xu, Rong
    Lord, Sarah A.
    Peterson, Ryan M.
    Fergason-Cantrell, Emily A.
    Lever, John R.
    Lever, Susan Z.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (01) : 222 - 230
1234